PHK
SPRB

Point72 Hong Kong’s Spruce Biosciences SPRB Stock Holding History

Point72 Hong Kong’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38
Closed -$6K – 2487
2022
Q1 		$6K Buy
+38
New +$7.07K ﹤0.01% 1666

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's SPRB Position: Q2 2022 in Review

Point72 Hong Kong sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 38 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in SPRB in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.

  • Point72 Hong Kong reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 38 Spruce Biosciences shares in Q2 2022, an estimated $6K.
  • Point72 Hong Kong first reported a position in Spruce Biosciences in Q1 2022 and held it in 1 quarter.
  • Point72 Hong Kong's Spruce Biosciences position peaked at $6K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.